Come up with a name for your new list and we'll add to it:
Edunn Biotechnology raised a round of funding on , . Investors include
St. Louis Arch Angels.
Edunn Biotechnology, Inc. is developing oligonucleotide drugs to treat central nervous system diseases. The company currently has two drugs in development. Edunn's OL-1 drug is designed to cure Alzhei…